Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Update

Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 8,700 shares, a decrease of 78.0% from the May 15th total of 39,600 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 87.0 days. Approximately 0.0% of the company's shares are short sold.

Pharma Mar Stock Performance

Shares of OTCMKTS PHMMF remained flat at $104.49 during midday trading on Friday. 2,500 shares of the company's stock were exchanged, compared to its average volume of 1,266. Pharma Mar has a fifty-two week low of $34.26 and a fifty-two week high of $105.60. The company's 50-day moving average is $90.69 and its 200-day moving average is $89.60. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.